Editas Medicine Statistics
NASDAQ: EDITHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
1.64-0.07 (-4.09%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Editas Medicine by the numbers
Editas Medicine has a market capitalization of $253.1 million based on 154.34M shares outstanding. With trailing EPS of $-0.54, Editas Medicine is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 35.0% below its 50-day average and 39.2% below its 200-day average.
Average daily trading volume is 2.63M shares, or about $4.3 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
EDIT valuation vs. peer median
| Metric | EDIT | Peer median | Difference |
|---|---|---|---|
| Market cap | $253.12M | $255.00M | -1% |
| Avg. volume | 2.63M | 885.38K | +197% |
Peer median across 8 companies: SABS, EIKN, OCGN, LXEO, PLX, AUTL, AGMB, KYTX.
Valuation
- Market cap
- $253.12M
- Price / sales (latest FY)
- 6.25
- EPS (TTM)
- $-0.54
- Shares outstanding
- 154.34M
Price and trading
- Previous close
- 1.71
- Open
- 1.69
- Day range
- 1.63 – 1.78
- 52-week range
- 1.63 – 3.94
- 52-week change
- -32.23%
- Beta
- —
- Volume
- 2.68M
- Average volume
- 2.63M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 9, 2026
Additional statistics
- Market Cap
- 253.12M
- Forward Pe
- -2.26
- Eps
- -0.54
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.94
- Week52 Low
- 1.63
- Avg Volume
- 2.63M
- Shares Outstanding
- 154.34M
- Ma50
- 2.52
- Ma200
- 2.70
- Earnings Date
- Nov 9, 2026
- Pct From52w High
- -58.38%
- Pct From52w Low
- 0.61%